Arrowstreet Capital, Limited Partnership »

Miragen Therapeutics shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 341k 31.12

More positions owned by Arrowstreet Capital, Limited Partnership

Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Lam Research Corp Com New (LRCX)
Adobe Systems Incorporated (ADBE)
Barrick Mng Corp Com Shs (B)
Mastercard Incorporated Cl A (MA)
Cisco Systems (CSCO)
Asml Holding N V N Y Registry Shs (ASML)
Amphenol Corp Cl A (APH)
Agnico (AEM)

View all positions for Arrowstreet Capital, Limited Partnership

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Fairmount Funds Management
VR Adviser
State Street Corporation
Deep Track Capital
Novo A/S
Geode Capital Management
Alliancebernstein
Tang Capital Management
Eversept Partners
Fisher Investments
Baker Bros. Advisors

View all funds holding Miragen Therapeutics